Positron Emission Tomography Imaging of Programmed Death 1 Expression in Cancer Patients Using $^{124}I$-Labeled Toripalimab: A Pilot Clinical Translation Study. Wang, S., Zhu, H., Ding, J., Wang, F., Meng, X., Ding, L., Zhang, Y., Li, N., Yao, S., Sheng, X., & Yang, Z. Clinical Nuclear Medicine, 00(00):0, 2021.
doi  bibtex   
@article{ToripalimabI124_2021,
author={Wang, Shujing and Zhu, Hua and Ding, Jin and Wang, Feng and Meng, Xiangxi and Ding, Lixin and Zhang, Yan and Li, Nan and Yao, Sheng and Sheng, Xinan and Yang, Zhi},
journal={Clinical Nuclear Medicine}, 
title={Positron Emission Tomography Imaging of {Programmed} {Death} 1 Expression in Cancer Patients Using $^{124}I$-Labeled Toripalimab: A Pilot Clinical Translation Study}, 
year={2021},
volume={00},
number={00},
pages={0},
doi={10.1097/RLU.0000000000003520}
}

Downloads: 0